Advanced search
Publication Cover
Acta Oncologica Volume 62, 2023 - Issue 1
Journal homepage
1,198
Views
0
CrossRef citations to date
0
Altmetric
Original Articles: Survivorship

Quality of life and mental health in real-world patients with resected stage III/IV melanoma receiving adjuvant immunotherapy

Sidsel Pedersena Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev and Gentofte, Copenhagen, DenmarkView further author information
,
Rikke B. Holmstroema Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev and Gentofte, Copenhagen, DenmarkView further author information
,
Annika von Heymannb Department of Oncology, Cancer Survivorship and Late Effects Research Center (CASTLE), Copenhagen University Hospital, Rigshospitalet, Copenhagen, DenmarkORCID Iconhttps://orcid.org/0000-0002-0900-5575View further author information
ORCID Icon,
Laerke K. Tolstrupc Department of Oncology, Odense University Hospital, Odense, DenmarkView further author information
,
Kasper Madsena Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev and Gentofte, Copenhagen, DenmarkView further author information
,
Morten Aagaard Petersend Department of Geriatrics and Palliative Medicine GP, Palliative Care Research Unit, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, DenmarkView further author information
,
Charlotte A. Haslunde Department of Oncology, Aalborg University Hospital, Aalborg, DenmarkView further author information
,
Christina H. Ruhlmannc Department of Oncology, Odense University Hospital, Odense, Denmark;f Department of Clinical Research, University of Southern Denmark, Odense, DenmarkView further author information
,
Henrik Schmidtg Department of Oncology, Aarhus University Hospital, Aarhus, DenmarkView further author information
,
Christoffer Johansenb Department of Oncology, Cancer Survivorship and Late Effects Research Center (CASTLE), Copenhagen University Hospital, Rigshospitalet, Copenhagen, DenmarkView further author information
,
Inge Marie Svanea Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev and Gentofte, Copenhagen, DenmarkORCID Iconhttps://orcid.org/0000-0002-9451-6037View further author information
ORCID Icon &
Eva Ellebaeka Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev and Gentofte, Copenhagen, DenmarkCorrespondence[email protected]
View further author information
 show all
Pages 62-69 | Received 29 Aug 2022, Accepted 31 Dec 2022, Published online: 16 Jan 2023

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.